Suppression of transglutaminase-2 is involved in anti-inflammatory actions of glucosamine in 12-O-Tetradecanoylphorbol- 13-acetate-induced skin inflammation

Biomolecules and Therapeutics

Volumn 20, Issue 4, 2012, Pages 380-385

  Park, Mi Kyung ^a   Cho, Sun A ^b   Lee, Hye Ja ^a   Lee, Eun Ji ^a   Kang, June Hee ^a   Kim, You Lee ^a   Kim, Hyun Ji ^a   Oh, Seung Hyun ^c   Choi, Changsun ^d   Lee, Ho ^c   Kim, Soo Youl ^e   Lee, Chang Hoon ^a  

^a Dongguk University   (South Korea)

^b AmorePacific Corporation   (South Korea)

^c Gachon University   (South Korea)

^d Chung Ang University   (South Korea)

^e National Cancer Center   (South Korea)

Author keywords

Cyclooxygenase 2; Glucosamine; NF B; Tgase 2 ( ) mice; TPA induced ear edema; Transglutaminase 2

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; GLUCOSAMINE; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG EFFECT; EAR; EAR EDEMA; ENZYME ACTIVITY; ENZYME REPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TREATMENT RESPONSE; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 84865178345     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.4.380     Document Type: Article

References (27)

1. Bradley, P. P., Priebat, D. A., Christensen, R. D. and Rothstein, G. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209.
2. Choi, Y. H., Son, K. H., Chang, H. W., Bae, K., Kang, S. S. and Kim, H. P. (2005) New anti-inflammatory formulation containing Synurus deltoides extract. Arch. Pharm. Res. 28, 848-853.
3. Chung, W. Y., Park, J. H., Kim, M. J., Kim, H. O., Hwang, J. K., Lee, S. K. and Park, K. K. (2007) Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and twostage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis 28, 1224-1231.
4. D'Ambrosio, E., Casa, B., Bompani, R., Scali, G. and Scali, M. (1981) Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 2, 504-508.
5. De Young, L. M., Kheifets, J. B., Ballaron, S. J. and Young, J. M. (1989) Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions 26, 335-341.
6. Eckert, R. L., Sturniolo, M. T., Broome, A. M., Ruse, M. and Rorke, E. A. (2005) Transglutaminase function in epidermis. J. Invest. Dermatol. 124, 481-492.
7. Hua, J., Sakamoto, K. and Nagaoka, I. (2002) Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils. J. Leukoc. Biol. 71, 632-640.
8. Jeong, K. C., Ahn, K. O., Lee, B. I., Lee, C. H. and Kim, S. Y. (2010) The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition. J. Cancer Res. Clin. Oncol. 136, 143-150.
9. Kim, C. H., Cheong, K. A., Park, C. D. and Lee, A. Y. (2011a) Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development. Scand. J. Immunol. 73, 536-545.
10. Kim, C. H., Cheong, K. A., Park, C. D. and Lee, A. Y. (2012) Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Scand. J. Immunol. 75, 471-478.
11. Kim, D. S., Kim, B., Tahk, H., Kim, D. H., Ahn, E. R., Choi, C., Jeon, Y., Park, S. Y., Lee, H., Oh, S. H. and Kim, S. Y. (2010) Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation. Biochem. Biophys. Res. Commun. 403, 479-484.
12. Kim, D. S., Park, K. S., Jeong, K. C., Lee, B. I., Lee, C. H. and Kim, S. Y. (2009) Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition. Cancer Lett. 273, 243-249.
13. Kim, J. C., Shin, J. Y., Shin, D. H., Kim, S. H., Park, S. H., Park, R. D., Park, S. C., Kim, Y. B. and Shin, Y. C. (2005) Synergistic antiinflammatory effects of pinitol and glucosamine in rats. Phytother. Res. 19, 1048-1051.
14. Kim, M. H., Nugroho, A., Choi, J., Park, J. H. and Park, H. J. (2011b) Rhododendrin, an analgesic/anti-inflammatory arylbutanoid glycoside, from the leaves of Rhododendron aureum. Arch. Pharm. Res. 34, 971-978.
15. Largo, R., Alvarez-Soria, M. A., Díez-Ortego, I., Calvo, E., Sánchez-Pernaute, O., Egido, J. and Herrero-Beaumont, G. (2003) Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11, 290-298.
16. Lee, C. H. and Kim, S. Y. (2009) NF-kappaB and therapeutic approach. Biomol. Ther. 17, 219-240.
17. Lee, J., Kim, Y. S., Choi, D. H., Bang, M. S., Han, T. R., Joh, T. H. and Kim, S. Y. (2004) Transglutaminase 2 induces nuclear factorkappaB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279, 53725-53735.
18. Lorand, L. and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4, 140-156.
19. Mehta, K. (2005) Mammalian transglutaminases: a family portrait. Prog. Exp. Tumor Res. 38, 1-18.
20. Mehta, K., Kumar, A. and Kim, H. I. (2010) Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem. Pharmacol. 80, 1921-1929.
21. Mhaouty-Kodja, S. (2004) Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol. Cell 96, 363-367.
22. Park, M. K. and Lee, C. H. (2011) Alpinia katsumadai suppresses migration and 12-O-tetradecanoylphorbol-13-acetate-induced invasion of HT-1080 cells through suppression of transglutaminase-2, matrix metalloproteinase-2, and matrix metalloproteinase-9 expression. Cancer Prevention Research 16, 326-332.
23. Rafi, M. M., Yadav, P. N. and Rossi, A. O. (2007) Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. Mol. Nutr. Food Res. 51, 587-593.
24. Shikhman, A. R., Kuhn, K., Alaaeddine, N. and Lotz, M. (2001) Nacetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J. Immunol. 166, 5155-5160.
25. Singh, S., Khajuria, A., Taneja, S. C., Khajuria, R. K., Singh, J. and Qazi, G. N. (2007) Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg. Med. Chem. Lett. 17, 3706-3711.
26. Song, H. Y., Lee, J. A., Ju, S. M., Yoo, K. Y., Won, M. H., Kwon, H. J., Eum, W. S., Jang, S. H., Choi, S. Y. and Park, J. (2008) Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem. Pharmacol. 75, 1348-1357.
27. Wangroongsub, Y., Tanavalee, A., Wilairatana, V. and Ngarmukos, S. (2010) Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study. J. Med. Assoc. Thai. 93, 805-811.